These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32196)

  • 1. Appraisal of ascorbic acid for acidifying the urine of methenamine-treated geriatric patients.
    Naccarto DV; Bell CJ; Lamy PP
    J Am Geriatr Soc; 1979 Jan; 27(1):34-7. PubMed ID: 32196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formaldehyde generation from methenamine salts in spinal cord injury.
    Devenport JK; Swenson JR; Dukes GE; Sonsalla PK
    Arch Phys Med Rehabil; 1984 May; 65(5):257-9. PubMed ID: 6712452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictability of methenamine efficacy based on type of urinary pathogen and pH.
    Nahata MC; Cummins BA; McLeod DC; Butler R
    J Am Geriatr Soc; 1981 May; 29(5):236-9. PubMed ID: 7014695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of urinary acidifiers on formaldehyde concentration and efficacy with methenamine therapy.
    Nahata MC; Cummins BA; McLeod DC; Schondelmeyer SW; Butler R
    Eur J Clin Pharmacol; 1982; 22(3):281-4. PubMed ID: 7106162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of urine pH and ascorbic acid on the rate of conversion of methenamine to formaldehyde.
    Strom JG; Jun HW
    Biopharm Drug Dispos; 1993 Jan; 14(1):61-9. PubMed ID: 8427945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of short-term high-dose treatment with methenamine hippurate on urinary infection in geriatric patients with an indwelling catheter. IV. Clinical evaluation.
    Norberg B; Norberg A; Parkhede U; Gippert H
    Eur J Clin Pharmacol; 1979 Jun; 15(5):357-61. PubMed ID: 37095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of ascorbic acid, hippuric acid, and methenamine (urinary formaldehyde) on the copper-reduction glucose test in geriatric patients.
    Nahata MC; McLeod DC
    J Am Geriatr Soc; 1980 May; 28(5):230-3. PubMed ID: 7365188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of methenamine in suppression of, or prophylaxis against, chronic urinary infection.
    Vainrub B; Musher DM
    Antimicrob Agents Chemother; 1977 Nov; 12(5):625-9. PubMed ID: 921259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antimicrobial activity of urine of paraplegic patients receiving methenamine mandelate.
    Pearman JW; Peterson GJ; Nash JB
    Invest Urol; 1978 Sep; 16(2):91-8. PubMed ID: 30734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methenamine therapy and urine acidification with ascorbic acid and cranberry juice.
    McLeod DC; Nahata MC
    Am J Hosp Pharm; 1978 Jun; 35(6):654. PubMed ID: 27096
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of short-term high-dose treatment with methenamine hippurate of urinary infection in geriatric patients with indwelling catheters. II. Evaluation by means of a quantified urine sediment.
    Norberg A; Norberg B; Parkhede U; Gippert H; Ekman R
    Ups J Med Sci; 1979; 84(1):75-82. PubMed ID: 442280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of short-term high-dose treatment with methenamine hippurate of urinary infection in geriatric patients with indwelling catheters. I. The preparation and morphology of a quantified urine sediment.
    Norberg B; Norberg A; Parkhede U; Gippert H; Akerman M
    Ups J Med Sci; 1979; 84(1):67-74. PubMed ID: 87049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbic acid and methenamine mandelate on the urinary pH of spinal cord injury patients.
    Lamid S
    J Urol; 1983 Apr; 129(4):845-6. PubMed ID: 6842722
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term acidification of urine in patients treated for infected renal stones.
    Wall I; Tiselius HG
    Urol Int; 1990; 45(6):336-41. PubMed ID: 2288050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methenaminenippurate (Hiprex), an alternatice in treatment of chronic urinary tract infections].
    Udjus ED; Edman T
    Tidsskr Nor Laegeforen; 1975 Feb; 95(6):384-6. PubMed ID: 235806
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized double-blind study of prophylactic methenamine hippurate treatment of patients with indwelling catheters.
    Norberg A; Norberg B; Parkhede U; Gippert H; Lundbeck K
    Eur J Clin Pharmacol; 1980 Nov; 18(6):497-500. PubMed ID: 7007058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dosage of urotropina].
    DE SOUZA AH
    Publ Farm (Sao Paulo); 1947 Apr; 12(48):5-12. PubMed ID: 20262006
    [No Abstract]   [Full Text] [Related]  

  • 18. Intermittent catheterization to obtain catheter-free bladder function in spinal cord injury.
    Sperling KB
    Arch Phys Med Rehabil; 1978 Jan; 59(1):4-8. PubMed ID: 619852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ascorbic acid on urine pH in patients with injured spinal cords.
    Hetey SK; Kleinberg ML; Parker WD; Johnson EW
    Am J Hosp Pharm; 1980 Feb; 37(2):235-7. PubMed ID: 7361797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with methenamine hippurate in the patient with a catheter.
    Norrman K; Wibell L
    J Int Med Res; 1976; 4(2):115-7. PubMed ID: 1026540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.